Literature DB >> 11357633

Virus isolation.

L M Hutt-Fletcher1, S M Turk.   

Abstract

Mesh：

Year:  2001        PMID： 11357633     DOI： 10.1385/1-59259-227-9:119

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  5 in total

1.  Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion.

Authors:  Austin N Kirschner; Amanda S Lowrey; Richard Longnecker; Theodore S Jardetzky
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

2.  Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.

Authors:  Carrie B Coleman; Eric M Wohlford; Nicholas A Smith; Christine A King; Julie A Ritchie; Paul C Baresel; Hiroshi Kimura; Rosemary Rochford
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

3.  Mapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL by using fluorescence polarization and cell-based fusion assays.

Authors:  Fengling Liu; Gaby Marquardt; Austin N Kirschner; Richard Longnecker; Theodore S Jardetzky
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

4.  Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2.

Authors:  Eric Gaudreault; Stéphanie Fiola; Martin Olivier; Jean Gosselin
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

5.  CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells.

Authors:  Nicholas A Smith; Carrie B Coleman; Benjamin E Gewurz; Rosemary Rochford
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.